6505--Epoetin RFP

The Department of Veterans Affairs National Acquisition Center is seeking a single contractor to provide seven different strengths of Epoetin injectable solution vials through solicitation 36E79725R0042. This pharmaceutical procurement will supply Epoetin products for distribution through VA and Department of Defense Pharmaceutical Prime Vendor Programs, serving multiple federal agencies including the VA, DoD, Bureau of Prisons, and Indian Health Service. Contractors must provide pricing for all line items and strengths, include National Drug Code numbers, demonstrate FDA approvals, and meet specific manufacturing facility and packaging requirements. The contract evaluation will be conducted using lowest-priced technically acceptable criteria, meaning the award will go to the offeror with the lowest price among those meeting all technical requirements. The solicitation closes on July 8, 2025 at 2:30 PM CT, with proposals required to be submitted electronically to specified VA contacts.

This procurement does not utilize any set-aside designation and operates under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees. The contract structure includes a base year followed by four one-year option periods, creating a potential five-year agreement for pharmaceutical supply services. Annual usage estimates range significantly from 3,181 to 63,901 vials depending on the specific Epoetin strength and requesting agency, indicating substantial volume requirements across the contract period. The procurement includes a 0.5% Cost Recovery Fee as part of the contract terms. The document does not identify any current incumbent contractors or specific award values, though the estimated usage quantities suggest this represents a significant pharmaceutical supply contract for federal healthcare operations.